Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 6Completed 4Terminated 3Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 5NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 76Breast Neoplasms 53Colorectal Neoplasms 51Neoplasms 38Advanced Solid Tumors 34Multiple Myeloma 32Prostatic Neoplasms 31Ovarian Neoplasms 28Neoplasm Metastasis 28Recurrence 27Lung Neoplasms 27Carcinoma, Hepatocellular 27Pancreatic Neoplasms 26Advanced Solid Tumor 22Small Cell Lung Carcinoma 20Leukemia, Myeloid, Acute 20Endometrial Neoplasms 19Melanoma 18Triple Negative Breast Neoplasms 16Squamous Cell Carcinoma of Head and Neck 14Lymphoma, Follicular 14Stomach Neoplasms 13Lymphoma, B-Cell 13Glioma 13Glioblastoma 13Uterine Cervical Neoplasms 12Lymphoma 11Head and Neck Neoplasms 11Solid Tumor 10Myasthenia Gravis 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × INDUSTRY × Clear-cell metastatic renal cell carcinoma × Clear all
NCT05698238 2023-03-15

CAMP1

Mabpro, a.s.

Phase 1 Not yet recruiting
50 enrolled
BreastGenitourinaryHead & NeckOther solid neoplasmThoracic

Clear-cell metastatic renal cell carcinoma, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡